In the paper of Wan and colleagues the defect in the inhibition of AP-1 by RARβ was investigated in the H1792 lung adenocarcinoma cells, resistant to the ATRA growth-inhibitory effect, despite the abundant levels of RARβ. The gene discussed is RARB; the disease is lung adenocarcinoma.